Myriad Genetics
MYGN
MYGN
188 hedge funds and large institutions have $1.88B invested in Myriad Genetics in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 65 increasing their positions, 64 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
9% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 23
1% less funds holding
Funds holding: 190 → 188 (-2)
1.75% less ownership
Funds ownership: 101.27% → 99.52% (-1.7%)
Holders
188
Holding in Top 10
1
Calls
$16.5M
Puts
$433K
Top Buyers
| 1 | +$8.38M | |
| 2 | +$7.68M | |
| 3 | +$6.92M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$6.65M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$6.39M |
Top Sellers
| 1 | -$22.9M | |
| 2 | -$11.1M | |
| 3 | -$10.7M | |
| 4 |
GCM
Glenview Capital Management
New York
|
-$10.4M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$8.46M |